For the past five years, you’ve likely noticed an uptick in the push to vaccinate pregnant women. If within the past five years you’ve been pregnant, you have almost certainly been asked (or even pushed) to take vaccinations. The concept, as the CDC and pharmaceutical companies would have it, is that they are “protecting the baby.”
Marketing vaccines to pregnant women is relatively new (a new low). Even with the momentum of vaccine campaigns throughout the 90s and into the 2000s, pregnant women were left alone. However, in 2009, pharma figured out that pregnant women were an enormous untapped market. 2009, of course, was the year of the swine flu and it is credited with starting the trend of giving flu vaccinations to pregnant women. In addition that year, tetanus-diphteria-pertussis shots were given as well. In some ways, 2009 was the year of the vaccine for the pregnant community.
GlaxoSmithKline Plc, Novavax Inc. and Pfizer Inc. have all placed their hats in the game. Pharma has “come together recently to make maternal immunization a viable focus,” says Ripley Ballou, head of Glaxo’s Rockville R&D Center. “The primary driver has been new and growing evidence of unmet medical need.” They are soon to target group B strep and respiratory syncytial virus vaccines, or “lung protection vaccines for newborns.” Booster shots are likely to become common practice throughout pregnancy. Imagine for a second the massive change of landscape we’ve experienced: It was only a handful of years ago that pregnant women were considered off limits by pharma. Today, they’ve become the new marketing frontier.
An entire slew of maternal vaccines are set to be introduced to our society. And even the mainstream can’t avoid the admission that it is a 100 percent profiteering landscape. Here is an article excerpt from Bloomberg.
It’s not any more. Companies including GlaxoSmithKline Plc, Novavax Inc. and Pfizer Inc. have concluded that baby-protecting vaccines for expectant mothers could be big business.
While the article goes on to cite instances from the 1960s as the inception, it does a poor job of convincing anyone that its original point, which is that pregnant women are big business, is anything less than ironclad truth. We can’t just turn a switch and decide that a once coveted and protected demographic of our society is now deemed a target market. Or can we? The truth is that we can because pregnant women might well be the easiest market. Pregnant women are scheduled “mandatory” doctor visits, making them sitting ducks for pharma’s scams. First-time mothers, in particular, are scared and doctors often use the “this vaccine lowers risk of losing the baby” pitches. For pharma and doctors, it’s an insulting and egregious sort of bottom feeding, preying on those at their weakest moments. But unless we wake up, it is clear that this situation will worsen.